Показано 0 из 0
Дата |
---|
16:49 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.48
|
2.50
|
2.64
|
2.48
|
2.68
|
2.48
|
|
|
86 356.36
|
240.00
|
2.54
|
2.60
|
2.25
|
2.25
|
2.59
|
2.48
|
|
|
1 026 938.42
|
3 761.00
|
2.23
|
2.32
|
2.31
|
2.22
|
2.36
|
2.23
|
|
|
424 675.12
|
2 061.00
|
2.29
|
2.47
|
2.29
|
2.26
|
2.3562
|
2.29
|
|
|
461 835.84
|
1 720.00
|
2.23
|
2.49
|
2.35
|
2.26
|
2.40
|
2.27
|
|
|
591 077.23
|
2 794.00
|
2.27
|
2.37
|
2.28
|
2.2001
|
2.37
|
2.35
|
|
|
572 080.07
|
1 958.00
|
2.30
|
2.42
|
2.35
|
2.26
|
2.365
|
2.33
|
|
|
464 576.31
|
1 857.00
|
2.35
|
2.46
|
2.39
|
2.32
|
2.5399
|
2.34
|
|
|
717 370.11
|
2 975.00
|
2.38
|
2.50
|
2.43
|
2.38
|
2.505
|
2.39
|
|
|
466 895.17
|
1 487.00
|
2.36
|
2.45
|
2.40
|
2.3409
|
2.45
|
2.40
|
|
|
964 181.01
|
3 358.00
|
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.